1. Side effects of erythromycin

   Newsletter Article 07 February 2013 Pages: 2 - 2

2. Managing benzodiazepine withdrawal

   Newsletter Article 07 February 2013 Pages: 2 - 2

3. Post marketing surveillance of triamterene + hydrochlorothiazide

   Newsletter Article 07 February 2013 Pages: 2 - 3

4. Digitalis and electrolyte abnormalities

   Newsletter Article 07 February 2013 Pages: 3 - 3

5. Hypomagnesaemia associated with aminoglycoside therapy

   Newsletter Article 07 February 2013 Pages: 4 - 4

6. Avoiding perineal irritation in patients receiving dexamethasone

   Newsletter Article 07 February 2013 Pages: 4 - 4

7. Aminophylline see Theophylline overdose

   Newsletter Article 07 February 2013 Pages: 4 - 4

8. Amiodarone

   Newsletter Article 07 February 2013 Pages: 4 - 4

9. Anticonvulsants

   Newsletter Article 07 February 2013 Pages: 4 - 4

10. Asparaginase*

    Newsletter Article 07 February 2013 Pages: 4 - 5

11. Bupivacaine

    Newsletter Article 07 February 2013 Pages: 5 - 5

12. Carbamazepine interaction

    Newsletter Article 07 February 2013 Pages: 5 - 5

13. Clobetasol

    Newsletter Article 07 February 2013 Pages: 5 - 5

14. Clonazepam interaction see Phenytoin interaction

    Newsletter Article 07 February 2013 Pages: 5 - 5

15. Cyclophosphamide

    Newsletter Article 07 February 2013 Pages: 5 - 5

16. Cyclosporin

    Newsletter Article 07 February 2013 Pages: 5 - 5

17. Desipramine*

    Newsletter Article 07 February 2013 Pages: 5 - 6

18. Diltiazem interaction see Carbamazepine interaction.

    Newsletter Article 07 February 2013 Pages: 6 - 6

19. Etretinate

    Newsletter Article 07 February 2013 Pages: 6 - 6

20. Febarbamate*

    Newsletter Article 07 February 2013 Pages: 6 - 6

21. Fentanyl*

    Newsletter Article 07 February 2013 Pages: 6 - 6

22. Hydrochlorothiazide*

    Newsletter Article 07 February 2013 Pages: 6 - 6

23. Isotretinoin

    Newsletter Article 07 February 2013 Pages: 6 - 7

24. Metyrapone*

    Newsletter Article 07 February 2013 Pages: 7 - 7

25. Mitotane interaction*

    Newsletter Article 07 February 2013 Pages: 7 - 7

26. Naftidrofuryl

    Newsletter Article 07 February 2013 Pages: 7 - 7

27. Neuroleptics

    Newsletter Article 07 February 2013 Pages: 7 - 7

28. Nifedipine*

    Newsletter Article 07 February 2013 Pages: 7 - 8

29. Phenytoin interaction

    Newsletter Article 07 February 2013 Pages: 8 - 8

30. Phenytoin overdose

    Newsletter Article 07 February 2013 Pages: 8 - 8

31. Propranolol overdose

    Newsletter Article 07 February 2013 Pages: 8 - 8

32. Quinine*

    Newsletter Article 07 February 2013 Pages: 8 - 8

33. Theophylline overdose

    Newsletter Article 07 February 2013 Pages: 8 - 9

34. Thyroxine

    Newsletter Article 07 February 2013 Pages: 9 - 9

35. Trazodone*

    Newsletter Article 07 February 2013 Pages: 9 - 9

36. Vaccine, swine flu

    Newsletter Article 07 February 2013 Pages: 9 - 9

37. Warfarin interaction see Mitotane Interaction

    Newsletter Article 07 February 2013 Pages: 9 - 9

38. Warfarin interaction

    Newsletter Article 07 February 2013 Pages: 9 - 9

39. Side effects of metoprolol

    Newsletter Article 07 February 2013 Pages: 9 - 10

40. Adverse effects of tocopherol

    Newsletter Article 07 February 2013 Pages: 11 - 11

41. Adverse effects of ascorbic acid

    Newsletter Article 07 February 2013 Pages: 11 - 11

42. Adverse effects of vitamin D

    Newsletter Article 07 February 2013 Pages: 11 - 12